ClinicalTrials.gov
ClinicalTrials.gov Menu

Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01516762
Expanded Access Status : No longer available
First Posted : January 25, 2012
Last Update Posted : July 14, 2014
Sponsor:
Information provided by (Responsible Party):
Bayer

No Study Results Posted on ClinicalTrials.gov for this Study
  Expanded Access Status : No longer available
  Primary Completion Date : No date given
  Study Completion Date : No date given